Telemedicine-Delivered Semaglutide and Tirzepatide Interventions Explored for Psychosocial Outcomes in Obesity
Psychosocial Outcomes in Telemedicine and Long‐Acting Incretin‐Specific Behavioral Intervention
Abstract
Research investigates the impact of long-acting incretin-based therapies like semaglutide and tirzepatide, delivered via telemedicine, on psychosocial outcomes in obesity management.